JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 45:1180-1185, doi:10.1016/j.jacc.2004.10.076
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lansky, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lansky, A. J.

FOCUS ISSUE: DRUG-ELUTING STENTS: TAXUS-IV

Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease

Alexandra J. Lansky, MD, FACC*, Ricardo A. Costa, MD*, Michael Mooney, MD, FACC{dagger}, Mark G. Midei, MD, FACC{ddagger}, Henry K. Lui, MD, FACC§, Warren Strickland, MD, FACC||, Roxana Mehran, MD, FACC*, Martin B. Leon, MD, FACC*, Mary E. Russell, MD, FACC, Stephen G. Ellis, MD, FACC#, Gregg W. Stone, MD, FACC*,* TAXUS-IV Investigators

* Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York
{dagger} Abbott Northwestern Hospital, Minneapolis, Minnesota
{ddagger} St. Joseph’s Medical Center Towson, Towson, Maryland
§ Research Associates of Jackson, Jackson, Tennessee
|| Huntsville Hospital, Huntsville, Alabama
Boston Scientific Corp., Natick, Massachusetts
# The Cleveland Clinic Foundation, Cleveland, Ohio

Manuscript received June 28, 2004; revised manuscript received October 18, 2004, accepted October 25, 2004.

* Reprint requests and correspondence: Dr. Gregg W. Stone, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, New York 10022. (Email: gstone{at}crf.org).

OBJECTIVES: We sought to determine whether gender influences the results of paclitaxel-eluting stent implantation.

BACKGROUND: The TAXUS-IV trial demonstrated the safety and effectiveness of the slow-release, polymer-based, paclitaxel-eluting TAXUS stent compared to bare-metal stents in patients undergoing elective coronary intervention. Whether these results are generalizable to women is not known.

METHODS: A total of 1,314 patients with coronary lesions 10- to 28-mm long in 2.5- to 3.75-mm vessels were randomized to TAXUS stent versus bare-metal EXPRESS stents (Boston Scientific Corp., Natick, Massachusetts). Outcomes examined were stratified by gender.

RESULTS: A total of 662 patients (including 187 women) were assigned to the TAXUS stent, and 652 (180 women) received the control stent. Women were older than men, and had more hypertension, diabetes, renal insufficiency, unstable angina, and heart failure, but less smoking. Among patients receiving the TAXUS stent, women compared with men had higher unadjusted one-year rates of target lesion revascularization (TLR) (7.6% vs. 3.2%, p = 0.03), though female gender was not an independent predictor of TLR (odds ratio [OR] = 1.72 [95% confidence interval (CI) 0.68 to 4.37], p = 0.25). Moreover, restenosis rates were similar in men and women treated with the TAXUS stent (8.6% vs. 7.6%, respectively, p = 0.80), as was late loss (0.22 vs. 0.23 mm, p = 0.90). Compared to control stents, treatment with the TAXUS stent in women resulted in a significant reduction in nine-month restenosis (8.6% vs. 29.2%, p = 0.0001) and one-year TLR (7.6% vs. 14.9%, p = 0.02). The only independent predictor of freedom from restenosis in women was randomization to the TAXUS stent (OR = 0.28 [95% CI 0.11 to 0.74], p = 0.01).

CONCLUSIONS: The benefits of the paclitaxel-eluting stent in reducing clinical and angiographic restenosis are generalizable to women.

Abbreviations and Acronyms
  CI = confidence interval
  MACE = major adverse cardiac events
  OR = odds ratio
  TLR = target lesion revascularization
  TVR = target vessel revascularization




This article has been cited by other articles:


Home page
CirculationHome page
P. Ortolani, M. Balducelli, P. Marzaroli, G. Piovaccari, A. Menozzi, V. Guiducci, P. Sangiorgio, F. Tarantino, G. Geraci, F. Castriota, et al.
Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesions: Results From a Real-World Multicenter Registry
Circulation, February 19, 2008; 117(7): 923 - 930.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Solinas, E. Nikolsky, A. J. Lansky, A. J. Kirtane, M.-C. Morice, J. J. Popma, J. Schofer, E. Schampaert, T. Pucelikova, J. Aoki, et al.
Gender-Specific Outcomes After Sirolimus-Eluting Stent Implantation
J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2111 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. M.M. van Beusekom, F. Saia, J. D. Zindler, P. A. Lemos, S. L. S.-t. Hoor, M. A.H. van Leeuwen, P. J. de Feijter, P. W. Serruys, and W. J. van der Giessen
Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus
Eur. Heart J., April 12, 2007; (2007) ehm064v1.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G W Mikhail
Coronary revascularisation in women
Heart, May 1, 2006; 92(suppl_3): iii19 - iii23.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Stramba-Badiale, K. M. Fox, S. G. Priori, P. Collins, C. Daly, I. Graham, B. Jonsson, K. Schenck-Gustafsson, and M. Tendera
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
Eur. Heart J., April 2, 2006; 27(8): 994 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 184 - 202.
[Full Text] [PDF]


Home page
BMJHome page
G. W Mikhail
Coronary heart disease in women
BMJ, September 3, 2005; 331(7515): 467 - 468.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. Kereiakes, R. E. Kuntz, L. Mauri, and M. W. Krucoff
Surrogates, substudies, and real clinical end points in trials of drug-eluting stents
J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1206 - 1212.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.